Pharmacy Medical News about Candidiasis

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Neonatal Peritoneal Candidiasis Successfully Treated with Anidulafungin Add-On Therapy
Annals of Pharmacotherapy, 10/22/09

Varisco BM et al. – Peritoneal candidiasis is a common complication of bowel perforation in neonates. Anidulafungin's pharmacokinetic and antifungal properties make it a viable therapeutic option in the treatment of this disease in critically ill infants and children.

<< Previous
Meeting New Challenges in the Management of Anemia of Chronic...

Next >>
Effectiveness of rosuvastatin in reducing LDL-C and target LDL-C...

Ascorbic acid decreases the antifungal effect of fluconazole in the treatment of candidiasis
Clinical and Experimental Pharmacology and Physiology, 11/05/09 Relevance Score: 87%

Incidence and predictors of invasive candidiasis associated with candidaemia in children
Mycoses, 10/19/09 Relevance Score: 87%

Autosomal dominant chronic mucocutaneous candidiasis and primary hypothyroidism complicated by oesophageal carcinoma
Clinical and Experimental Dermatology, 10/06/09 Relevance Score: 87%

Candidiasis: New agents for invasive infections
The Clinical Advisor, 10/06/09 Relevance Score: 85%

Efficient diagnosis of vulvovaginal candidiasis using a new rapid immunochromatography test
Journal of Clinical Microbiology, 10/13/09 Relevance Score: 82%